MCM
ALLR

Militia Capital Management’s Allarity Therapeutics ALLR Stock Holding History

Militia Capital Management’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Buy
+98,978
New +$140K ﹤0.01% 275

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Militia Capital Management's ALLR Position: Q2 2026 in Review

Militia Capital Management opened a new position in Allarity Therapeutics (ALLR) in Q2 2026: 98,978 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #275 among its holdings.

19 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • Militia Capital Management held 98,978 shares of Allarity Therapeutics worth $128K as of Q2 2026.
  • Allarity Therapeutics was a new Militia Capital Management position in Q2 2026.
  • Allarity Therapeutics made up ﹤0.01% of Militia Capital Management's portfolio in Q2 2026, its #275 holding.
  • 19 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Militia Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.